| B7-H3: a costimulatory molecule for T cell activation and IFN-γ production AI Chapoval, J Ni, JS Lau, RA Wilcox, DB Flies, D Liu, H Dong, GL Sica, ... Nature immunology 2 (3), 269-274, 2001 | 1269 | 2001 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 543 | 2018 |
| Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma J Iqbal, G Wright, C Wang, A Rosenwald, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 123 (19), 2915-2923, 2014 | 523 | 2014 |
| Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management RA Wilcox American journal of hematology 92 (10), 1085-1102, 2017 | 522 | 2017 |
| Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors RA Wilcox, DB Flies, G Zhu, AJ Johnson, K Tamada, AI Chapoval, ... The Journal of clinical investigation 109 (5), 651-659, 2002 | 383 | 2002 |
| Cutting edge: expression of functional CD137 receptor by dendritic cells RA Wilcox, AI Chapoval, KS Gorski, M Otsuji, T Shin, DB Flies, K Tamada, ... The Journal of Immunology 168 (9), 4262-4267, 2002 | 339 | 2002 |
| Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial A Ahmed, SA Merrill, F Alsawah, P Bockenstedt, E Campagnaro, ... The Lancet Haematology 6 (12), e630-e637, 2019 | 254 | 2019 |
| B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders RA Wilcox, AL Feldman, DA Wada, ZZ Yang, NI Comfere, H Dong, ... Blood, The Journal of the American Society of Hematology 114 (10), 2149-2158, 2009 | 252 | 2009 |
| Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma TB Heavican, A Bouska, J Yu, W Lone, C Amador, Q Gong, W Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 133 (15), 1664-1676, 2019 | 231 | 2019 |
| Strategies for antigen loading of dendritic cells to enhance the antitumor immune response SE Strome, S Voss, R Wilcox, TL Wakefield, K Tamada, D Flies, ... Cancer research 62 (6), 1884-1889, 2002 | 229 | 2002 |
| Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity RA Wilcox, K Tamada, SE Strome, L Chen The Journal of Immunology 169 (8), 4230-4236, 2002 | 224 | 2002 |
| Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management SM Ansell American journal of hematology 95 (8), 978-989, 2020 | 219* | 2020 |
| The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma RA Wilcox, K Ristow, TM Habermann, DJ Inwards, INM Micallef, ... Leukemia 25 (9), 1502-1509, 2011 | 211 | 2011 |
| GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features T Wang, AL Feldman, DA Wada, YE Lu, A Polk, R Briski, K Ristow, ... Blood, The Journal of the American Society of Hematology 123 (19), 3007-3015, 2014 | 186 | 2014 |
| Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells RA Wilcox, DA Wada, SC Ziesmer, SF Elsawa, NI Comfere, AB Dietz, ... Blood, The Journal of the American Society of Hematology 114 (14), 2936-2944, 2009 | 178 | 2009 |
| Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo RA Wilcox, K Tamada, DB Flies, G Zhu, AI Chapoval, BR Blazar, WM Kast, ... Blood 103 (1), 177-184, 2004 | 174 | 2004 |
| The goals and strategies of robust methods RR Wilcox British Journal of Mathematical and Statistical Psychology 51 (1), 1-39, 1998 | 143 | 1998 |
| Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management AC Hristov, T Tejasvi, RA Wilcox American journal of hematology 94 (9), 1027-1041, 2019 | 126 | 2019 |
| Cancer-associated myeloproliferation: old association, new therapeutic target RA Wilcox Mayo Clinic Proceedings 85 (7), 656-663, 2010 | 121 | 2010 |
| A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders T Velusamy, MJ Kiel, AA Sahasrabuddhe, D Rolland, CA Dixon, ... Blood, The Journal of the American Society of Hematology 124 (25), 3768-3771, 2014 | 101 | 2014 |
